<iframe src="//www.googletagmanager.com/ns.html?id=GTM-5TSRKG" height="0" width="0" style="display: none; visibility: hidden">
Research Article
No access
Published Online: 19 March 2008

A Plasmid-Based Self-Amplifying Sindbis Virus Vector

Publication: Human Gene Therapy
Volume 6, Issue Number 9

ABSTRACT

Sindbis virus was used as a self-amplifying eukaryotic expression vector. A recombinant cDNA genome of this (+)-strand RNA virus was placed under the transcriptional control of a Rous sarcoma virus LTR (RSV) promoter. Transfection of this plasmid construct into mammalian cell lines (3T3, HepG2, and 293 cells) resulted in expression of the luciferase reporter gene. High-expression levels were also measured after transfection into primary rat myoblasts. In differentiated myotubes, expression levels generated by the Sindbis virus vector were up to 200 times higher than those obtained with a conventional RSV expression vector. In vivo expression was detected after injection of plasmid DNA into mouse quadriceps. In vivo expression was transient and undetectable by day 16. This self-amplifying expression vector can be used for generating high-level expression of transgenes in vitro and in vivo. Its transient nature in vivo could allow for safe, short-term delivery of gene products in gene therapy protocols. It should facilitate the study of Sindbis and other RNA viruses.

Overview summary

In transfection experiments, expression levels are related to promoter strength and the number of transfected plasmid molecules. To improve expression levels, a self-amplifying vector was developed. This plasmid-based vector consists of a cDNA copy of the Sindbis virus under transcriptional control of the RSV promoter. Transfection of this vector into mammalian cells resulted in much higher levels of cytoplasmic mRNA as compared to a conventional expression vector.

Get full access to this article

View all available purchase options and get full access to this article.

Information & Authors

Information

Published In

cover image Human Gene Therapy
Human Gene Therapy
Volume 6Issue Number 9September 1995
Pages: 1161 - 1167
PubMed: 8527474

History

Published online: 19 March 2008
Published in print: September 1995
Accepted: 9 May 1995
Received: 7 February 1995

Permissions

Request permissions for this article.

Topics

Authors

Affiliations

Jeffrey S. Latendresse
1Department of Pediatrics and Medical Genetics, University of Wisconsin, Madison, WI 53705. 2Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO 63110.

Notes

Address reprint requests to: Dr. Jon A. Wolff, 355 Waisman Center, University of Wisconsin-Madison, 1500 Highland Avenue, Madison, WI 53705

Metrics & Citations

Metrics

Citations

Export citation

Select the format you want to export the citations of this publication.

View Options

Get Access

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.

Society Access

If you are a member of a society that has access to this content please log in via your society website and then return to this publication.

Restore your content access

Enter your email address to restore your content access:

Note: This functionality works only for purchases done as a guest. If you already have an account, log in to access the content to which you are entitled.

View options

PDF/EPUB

View PDF/ePub

Media

Figures

Other

Tables

Share

Share

Copy the content Link

Share on social media

Back to Top